Optiver Weighs In…

September 23rd, 2021 | For Subscribers

First HRT. Then Jump. Now, Optiver joins the chorus representing a collective "squeal" by a subset of secretive prop firms attempting to influence changes to US equity and options market structure...

Sign In Required

Create a free account to browse our content, or sign in if you already have one.

Create a free account to get started.

Create Free Account

About Paul Rowady

Paul Rowady is the Director of Research for Alphacution, a research and strategic advisory platform uniquely focused on modeling and benchmarking the impacts of technology on global financial markets and the businesses of trading and asset management. He is a 35-year veteran of the proprietary, quantitative and derivatives trading arenas.

Contact: [email protected]

Related Articles

Receive updates on Alphacution's latest research.